Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant

Clinical trial NCT06337331 · WITHDRAWN

Trial details

NCT number: NCT06337331
Sponsor: Northside Hospital, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndromes

Start date: 2024-08-31
Primary completion: 2026-08-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.